Pharma

Pharma

FDA adcomm votes down Secura's PI3K drug in CLL

An FDA advisory committee sided with the FDA in a 8-4 vote against Copiktra’s currently approved use in relapsed or refractory CLL/SLL.
Angus Liu Sep 23, 2022 3:06pm

FDA adcomm rejects Oncopeptides' multiple myeloma drug Pepaxto

Sep 23, 2022 11:40am

Small molecule biomarkers to align patients, disease and therapy

Sep 19, 2022 8:00am

AZ, Merck withdraw Lynparza in late-line ovarian cancer

Sep 23, 2022 11:26am

A new way to access scientific papers?

Sep 19, 2022 8:00am

Pfizer and the U.S. have slimmed down a COVID shot donation deal

Sep 23, 2022 10:58am